AN2 Therapeutics (ANTX) Prepaid Assets (2021 - 2026)

AN2 Therapeutics (ANTX) has reported Prepaid Assets for 6 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 11.84% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 11.84% YoY), while the FY2025 annual figure was $1.9 million, down 26.78% from the prior year.
• Prepaid Assets advanced to $2.2 million in Q1 2026 per ANTX's latest filing, from $1.9 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $4.6 million in Q2 2025 and bottomed at $1.4 million in Q1 2022.
• Historically, Prepaid Assets has averaged $2.7 million across 5 years, with a median of $2.6 million in 2023.
• Annual changes were most pronounced in 2024 — Prepaid Assets jumped 64.53% — and 2025, when it tumbled 50.86%.
• AN2 Therapeutics' Prepaid Assets stood at $2.5 million in 2022, then gained by 28.02% to $3.2 million in 2023, then slipped by 17.68% to $2.6 million in 2024, then dropped by 26.78% to $1.9 million in 2025, then rose by 13.79% to $2.2 million in 2026.
• Business Quant data shows ANTX's Prepaid Assets at $2.2 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.